Cornerstone Investment Partners Acquires 7,649 Shares in Bruker

Cornerstone Investment Partners LLC has purchased a new position in Bruker Corporation, acquiring 7,649 shares of the medical research company during the second quarter of 2023. The investment is valued at approximately $315,000, according to data from HoldingsChannel.com. This acquisition reflects a growing interest from institutional investors in Bruker, which operates in the scientific instrument sector.

Several hedge funds have recently adjusted their holdings in Bruker. The Teacher Retirement System of Texas increased its stake by 5.1% in the first quarter, now owning 29,045 shares valued at $1,212,000. Additionally, OneDigital Investment Advisors LLC grew its investment by 38.0%, holding 5,522 shares worth $230,000 after acquiring an additional 1,520 shares. Envestnet Asset Management Inc. also raised its holdings by 7.3%, owning 380,096 shares valued at approximately $15.87 million.

Another significant increase came from Linden Thomas Advisory Services LLC, which raised its stake by 3.5%, now holding 19,356 shares valued at $808,000. Finally, Allworth Financial LP lifted its holdings by an impressive 92.4%, now owning 758 shares worth $30,000. Collectively, hedge funds and institutional investors own 79.52% of Bruker’s stock.

Analyst Ratings and Insider Activity

Recent assessments from equity analysts have resulted in varying opinions on Bruker shares, identified by the ticker BRKR. Citigroup lowered its price target from $40.00 to $38.00, maintaining a “neutral” rating. In contrast, Wells Fargo & Company reduced its price objective from $50.00 to $48.00 while assigning an “overweight” rating. Cowen reiterated a “hold” rating, and Weiss Ratings issued a “sell (d+)” rating. Meanwhile, Jefferies Financial Group set a price target of $60.00 and rated the stock as a “buy.” Currently, five analysts recommend buying Bruker, six suggest holding, and one analyst has issued a sell rating. The consensus rating stands at “Hold” with an average price target of $48.30, according to MarketBeat.

In a related matter, Cynthia M. Friend, a director at Bruker, recently sold 3,535 shares on September 12, 2023, at an average price of $32.25, totaling $114,003.75. This transaction reduced her holdings to 18,016 shares, valued at approximately $581,016, marking a 16.40% decrease in her position. Insider ownership currently represents 27.30% of the company’s stock.

Bruker’s Market Performance and Future Outlook

On the trading front, shares of Bruker Corporation opened at $39.31 on Friday. The company reports a debt-to-equity ratio of 1.31, a current ratio of 1.61, and a quick ratio of 0.70. The stock’s performance over the last fifty days averages at $34.90, while the two-hundred-day moving average stands at $37.05. Over the past year, Bruker’s shares reached a low of $28.53 and a high of $64.64, with a market capitalization of $5.96 billion.

Bruker announced its latest quarterly earnings on November 3, 2023. The company reported earnings per share (EPS) of $0.45, surpassing analysts’ expectations of $0.33 by $0.12. The firm recorded $860.50 million in revenue, exceeding the consensus estimate of $847.40 million. Despite this performance, Bruker’s revenue reflects a 0.5% decrease compared to the same quarter last year. Analysts predict that Bruker will post an EPS of 2.69 for the current year and have set the fiscal year 2025 guidance at $1.85-$1.90.

Additionally, Bruker has declared a quarterly dividend of $0.05, scheduled to be paid on January 2, 2024, to investors of record on December 8, 2023. This dividend represents an annualized payout of $0.20, equating to a dividend yield of 0.5%. The ex-dividend date is also set for December 8, 2023, with the company’s current payout ratio standing at -125.00%.

Bruker Corporation, along with its subsidiaries, specializes in the development, manufacturing, and distribution of scientific instruments and analytical solutions internationally. The company operates through various segments, including Bruker Scientific Instruments, BioSpin, CALID, Nano, and Bruker Energy & Supercon Technologies.